A Study of Prevalence of EGFR Mutations in Participants With NSCLC

An Epidemiology Study of the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients Diagnosed With Non-squamous Non-small Cell Lung Cancer (NSCLC)

This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).

Inclusion Criteria:

• Informed consent form signature
• Jordanian male and female participants greater than or equal to (>=) 18 years of age
• Histologically confirmed NSCLC
• Not participating in a study that involves an investigational agent within 30 days prior to enrollment

Exclusion Criteria:

• Other primary malignancy
• Fine needle aspiration samples